Annual Revenue
$5.64 M
+$3.96 M+236.72%
31 December 2023
Summary:
Evogene annual revenue is currently $5.64 million, with the most recent change of +$3.96 million (+236.72%) on 31 December 2023. During the last 3 years, it has risen by +$4.60 million (+442.31%). EVGN annual revenue is now -67.92% below its all-time high of $17.58 million, reached on 31 December 2013.EVGN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$1.80 M
+$882.00 K+96.50%
30 September 2024
Summary:
Evogene quarterly revenue is currently $1.80 million, with the most recent change of +$882.00 thousand (+96.50%) on 30 September 2024. Over the past year, it has dropped by -$1.97 million (-52.32%). EVGN quarterly revenue is now -62.72% below its all-time high of $4.82 million, reached on 31 December 2012.EVGN Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$7.48 M
-$1.97 M-20.86%
30 September 2024
Summary:
Evogene TTM revenue is currently $7.48 million, with the most recent change of -$1.97 million (-20.86%) on 30 September 2024. Over the past year, it has increased by +$1.76 million (+30.69%). EVGN TTM revenue is now -58.42% below its all-time high of $17.99 million, reached on 30 September 2013.EVGN TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVGN Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +236.7% | -52.3% | +30.7% |
| 3 y3 years | +442.3% | +1089.4% | +670.9% |
| 5 y5 years | +222.8% | +1751.5% | +487.9% |
EVGN Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +506.4% | -57.1% | +1089.4% | -20.9% | +796.6% |
| 5 y | 5 years | at high | +649.0% | -57.1% | +2294.7% | -20.9% | +1457.9% |
| alltime | all time | -67.9% | +649.0% | -62.7% | +2294.7% | -58.4% | +1457.9% |
Evogene Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.80 M(+96.5%) | $7.48 M(-20.9%) |
| June 2024 | - | $914.00 K(-78.2%) | $9.45 M(+2.8%) |
| Mar 2024 | - | $4.19 M(+624.9%) | $9.19 M(+62.9%) |
| Dec 2023 | $5.64 M(+236.7%) | $578.00 K(-84.7%) | $5.64 M(-1.4%) |
| Sept 2023 | - | $3.77 M(+476.0%) | $5.72 M(+136.3%) |
| June 2023 | - | $654.00 K(+2.0%) | $2.42 M(+16.5%) |
| Mar 2023 | - | $641.00 K(-2.9%) | $2.08 M(+24.1%) |
| Dec 2022 | $1.68 M(+80.1%) | $660.00 K(+41.6%) | $1.68 M(+26.3%) |
| Sept 2022 | - | $466.00 K(+49.4%) | $1.33 M(+31.2%) |
| June 2022 | - | $312.00 K(+31.6%) | $1.01 M(+21.2%) |
| Mar 2022 | - | $237.00 K(-23.8%) | $834.00 K(-10.3%) |
| Dec 2021 | $930.00 K(-10.6%) | $311.00 K(+106.0%) | $930.00 K(-4.1%) |
| Sept 2021 | - | $151.00 K(+11.9%) | $970.00 K(-14.5%) |
| June 2021 | - | $135.00 K(-59.5%) | $1.14 M(-12.6%) |
| Mar 2021 | - | $333.00 K(-5.1%) | $1.30 M(+24.8%) |
| Dec 2020 | $1.04 M(+38.1%) | $351.00 K(+11.1%) | $1.04 M(+29.2%) |
| Sept 2020 | - | $316.00 K(+6.0%) | $805.00 K(+37.4%) |
| June 2020 | - | $298.00 K(+297.3%) | $586.00 K(+22.1%) |
| Mar 2020 | - | $75.00 K(-35.3%) | $480.00 K(-36.3%) |
| Dec 2019 | $753.00 K(-56.9%) | $116.00 K(+19.6%) | $753.00 K(-40.8%) |
| Sept 2019 | - | $97.00 K(-49.5%) | $1.27 M(-17.5%) |
| June 2019 | - | $192.00 K(-44.8%) | $1.54 M(-10.8%) |
| Mar 2019 | - | $348.00 K(-45.2%) | $1.73 M(-1.0%) |
| Dec 2018 | $1.75 M | $635.00 K(+73.0%) | $1.75 M(-5.4%) |
| Sept 2018 | - | $367.00 K(-3.2%) | $1.85 M(-17.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | $379.00 K(+3.6%) | $2.23 M(-26.4%) |
| Mar 2018 | - | $366.00 K(-50.1%) | $3.03 M(-10.5%) |
| Dec 2017 | $3.38 M(-48.3%) | $734.00 K(-1.9%) | $3.38 M(-11.7%) |
| Sept 2017 | - | $748.00 K(-36.5%) | $3.83 M(-17.1%) |
| June 2017 | - | $1.18 M(+63.4%) | $4.62 M(-12.0%) |
| Mar 2017 | - | $721.00 K(-38.9%) | $5.25 M(-19.8%) |
| Dec 2016 | $6.54 M(-41.2%) | $1.18 M(-23.2%) | $6.54 M(-16.4%) |
| Sept 2016 | - | $1.54 M(-15.0%) | $7.82 M(-18.5%) |
| June 2016 | - | $1.81 M(-10.3%) | $9.60 M(-8.1%) |
| Mar 2016 | - | $2.02 M(-18.1%) | $10.44 M(-6.2%) |
| Dec 2015 | $11.13 M(-23.3%) | $2.46 M(-25.6%) | $11.13 M(-9.6%) |
| Sept 2015 | - | $3.31 M(+24.6%) | $12.31 M(+1.2%) |
| June 2015 | - | $2.66 M(-1.7%) | $12.16 M(-8.9%) |
| Mar 2015 | - | $2.70 M(-25.8%) | $13.36 M(-8.0%) |
| Dec 2014 | $14.51 M(-17.5%) | $3.64 M(+15.0%) | $14.51 M(-5.1%) |
| Sept 2014 | - | $3.16 M(-17.8%) | $15.28 M(-6.5%) |
| June 2014 | - | $3.85 M(-0.2%) | $16.35 M(-2.8%) |
| Mar 2014 | - | $3.86 M(-12.6%) | $16.82 M(-4.3%) |
| Dec 2013 | $17.58 M(+3.0%) | $4.41 M(+4.2%) | $17.58 M(-2.3%) |
| Sept 2013 | - | $4.23 M(-1.9%) | $17.99 M(+1.5%) |
| June 2013 | - | $4.32 M(-6.5%) | $17.72 M(+1.3%) |
| Mar 2013 | - | $4.62 M(-4.2%) | $17.49 M(+35.9%) |
| Dec 2012 | $17.07 M(+14.6%) | $4.82 M(+21.5%) | $12.87 M(+59.8%) |
| Sept 2012 | - | $3.97 M(-2.9%) | $8.05 M(+97.1%) |
| June 2012 | - | $4.09 M | $4.09 M |
| Dec 2011 | $14.90 M | - | - |
FAQ
- What is Evogene annual revenue?
- What is the all time high annual revenue for Evogene?
- What is Evogene annual revenue year-on-year change?
- What is Evogene quarterly revenue?
- What is the all time high quarterly revenue for Evogene?
- What is Evogene quarterly revenue year-on-year change?
- What is Evogene TTM revenue?
- What is the all time high TTM revenue for Evogene?
- What is Evogene TTM revenue year-on-year change?
What is Evogene annual revenue?
The current annual revenue of EVGN is $5.64 M
What is the all time high annual revenue for Evogene?
Evogene all-time high annual revenue is $17.58 M
What is Evogene annual revenue year-on-year change?
Over the past year, EVGN annual revenue has changed by +$3.96 M (+236.72%)
What is Evogene quarterly revenue?
The current quarterly revenue of EVGN is $1.80 M
What is the all time high quarterly revenue for Evogene?
Evogene all-time high quarterly revenue is $4.82 M
What is Evogene quarterly revenue year-on-year change?
Over the past year, EVGN quarterly revenue has changed by -$1.97 M (-52.32%)
What is Evogene TTM revenue?
The current TTM revenue of EVGN is $7.48 M
What is the all time high TTM revenue for Evogene?
Evogene all-time high TTM revenue is $17.99 M
What is Evogene TTM revenue year-on-year change?
Over the past year, EVGN TTM revenue has changed by +$1.76 M (+30.69%)